Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Manzini

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
International Journal of Cancer|June 19, 2009
Antitumor activity of delimotecan against human metastatic melanoma: pharmacokinetics and molecular determinantsMario Bigioni, Massimo Parlani, Alessandro Bressan, et al.
British Journal of Pharmacology|April 14, 2011
Rosuvastatin does not affect human apolipoprotein A-I expression in genetically modified mice: a clue to the disputed effect of statins on HDLMarta Marchesi, Cinzia Parolini, Silvia Caligari, et al.
Thrombosis and Haemostasis|October 25, 2021
Rupatadine Treatment Is Associated with Atherosclerosis Worsening and Altered T Lymphocyte RecruitmentMarco Busnelli, Stefano Manzini, Alice Colombo, et al.
The Canadian Journal of Cardiology|September 10, 2019
Infusions of Large Synthetic HDL Containing Trimeric apoA-I Stabilize Atherosclerotic Plaques in Hypercholesterolemic RabbitsCinzia Parolini, Maria Pia Adorni, Marco Busnelli, et al.
British Journal of Pharmacology|October 18, 2019
Fenretinide treatment accelerates atherosclerosis development in apoE-deficient mice in spite of beneficial metabolic effectsMarco Busnelli, Stefano Manzini, Fabrizia Bonacina, et al.
Scientific Reports|March 15, 2017
Liver-specific deletion of the Plpp3 gene alters plasma lipid composition and worsens atherosclerosis in apoE<sup>-/-</sup> miceMarco Busnelli, Stefano Manzini, Mika Hilvo, et al.
European Journal of Pharmacology|September 21, 2002
Pharmacological profile of MEN91507, a new CysLT(1) receptor antagonistFrancesc Cabré, Assumpta Carabaza, Ana Maria García, et al.
Molecular Nutrition & Food Research|June 25, 2020
Fat-Shaped Microbiota Affects Lipid Metabolism, Liver Steatosis, and Intestinal Homeostasis in Mice Fed a Low-Protein DietMarco Busnelli, Stefano Manzini, Amin Jablaoui, et al.
Biofabrication|April 15, 2026
Organobodies: A robust and size-controllable system for generating scalable hiPSC-derived liver organoids for drug toxicity screeningMostafa Kiamehr, Stefano Manzini, Burak Toprakhisar, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 1, 2012
Reduced biliary sterol output with no change in total faecal excretion in mice expressing a human apolipoprotein A-I variantCinzia Parolini, Silvia Caligari, Donatella Gilio, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
International Journal of Cancer|June 19, 2009
Antitumor activity of delimotecan against human metastatic melanoma: pharmacokinetics and molecular determinantsMario Bigioni, Massimo Parlani, Alessandro Bressan, et al.
British Journal of Pharmacology|April 14, 2011
Rosuvastatin does not affect human apolipoprotein A-I expression in genetically modified mice: a clue to the disputed effect of statins on HDLMarta Marchesi, Cinzia Parolini, Silvia Caligari, et al.
Thrombosis and Haemostasis|October 25, 2021
Rupatadine Treatment Is Associated with Atherosclerosis Worsening and Altered T Lymphocyte RecruitmentMarco Busnelli, Stefano Manzini, Alice Colombo, et al.
The Canadian Journal of Cardiology|September 10, 2019
Infusions of Large Synthetic HDL Containing Trimeric apoA-I Stabilize Atherosclerotic Plaques in Hypercholesterolemic RabbitsCinzia Parolini, Maria Pia Adorni, Marco Busnelli, et al.
British Journal of Pharmacology|October 18, 2019
Fenretinide treatment accelerates atherosclerosis development in apoE-deficient mice in spite of beneficial metabolic effectsMarco Busnelli, Stefano Manzini, Fabrizia Bonacina, et al.
Scientific Reports|March 15, 2017
Liver-specific deletion of the Plpp3 gene alters plasma lipid composition and worsens atherosclerosis in apoE<sup>-/-</sup> miceMarco Busnelli, Stefano Manzini, Mika Hilvo, et al.
European Journal of Pharmacology|September 21, 2002
Pharmacological profile of MEN91507, a new CysLT(1) receptor antagonistFrancesc Cabré, Assumpta Carabaza, Ana Maria García, et al.
Molecular Nutrition & Food Research|June 25, 2020
Fat-Shaped Microbiota Affects Lipid Metabolism, Liver Steatosis, and Intestinal Homeostasis in Mice Fed a Low-Protein DietMarco Busnelli, Stefano Manzini, Amin Jablaoui, et al.
Biofabrication|April 15, 2026
Organobodies: A robust and size-controllable system for generating scalable hiPSC-derived liver organoids for drug toxicity screeningMostafa Kiamehr, Stefano Manzini, Burak Toprakhisar, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 1, 2012
Reduced biliary sterol output with no change in total faecal excretion in mice expressing a human apolipoprotein A-I variantCinzia Parolini, Silvia Caligari, Donatella Gilio, et al.
Pageof 5